Anzahl der Publikationen: 4
2016
Nevens, F.; Andreone, P.; Mazzella, G.; Strasser, S. I.; Bowlus, C.; Invernizzi, P.; Drenth, J. P. H.; Pockros, P. J.; Regula, J.; Beuers, U.; Trauner, M.; Jones, D. E.; Floreani, A.; Hohenester, S.; Luketic, V.; Shiffman, M.; Erpecum, K. J. van; Vargas, V.; Vincent, C.; Hirschfield, G. M.; Shah, H.; Hansen, B.; Lindor, K. D.; Marschall, H.-U.; Kowdley, K. V.; Hooshmand-Rad, R.; Marmon, T.; Sheeron, S.; Pencek, R.; MacConell, L.; Pruzanski, M. und Shapiro, D.
(2016):
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.
In: New England Journal of Medicine, Bd. 375, Nr. 7: S. 631-643
Ariza, X.; Graupera, I.; Coll, M.; Solà, E.; Barreto, R.; García, E.; Moreira, R.; Elia, C.; Morales-Ruiz, M.; Llopis, M.; Huelin, P.; Solé, C.; Fabrellas, N.; Weiss, E.; Nevens, F.; Gerbes, A.; Trebicka, J.; Saliba, F.; Fondevila, C.; Hernández-Gea, V.; Fernández, J.; Bernardi, M.; Arroyo, V.; Jiménez, W.; Deulofeu, C.; Pavesi, M.; Angeli, P.; Jalan, R.; Moreau, R.; Sancho-Bru, P. und Ginès, P.
(2016):
Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis.
In: Journal of Hepatology, Bd. 65, Nr. 1: S. 57-65
Trauner, M.; Nevens, F.; Andreone, P.; Mazzella, G.; Strasser, S.; Bowlus, C.; Invernizzi, P.; Drenth, J.; Pockros, P.; Regula, J.; Floreani, A.; Hohenester, S.; Luketic, V.; Shiffman, M.; Erpecum, K. van; Vargas, V.; Vincent, C.; Hansen, B.; MacConell, L.; Marmon, T. und Shapiro, D.
(2016):
Durable response in the markers of cholestasis through 18 months of open-label extension with obeticholic acid in primary biliary cholangitis.
In: Digestive and Liver Disease, Bd. 48, E236-E236
Trauner, M.; Fickert, P.; Hirschfield, G.; Reiter, F.; Altorjay, I.; Marschall, U.; Färkkilä, M.; Schramm, C.; Spengler, U.; Chapman, R.; Bergquist, A.; Schrumpf, E.; Nevens, F.; Halilbasic, E.; Greinwald, R.; Proels, M. und Manns, M. P.
(2016):
Norursodeoxycholic Acid Improves Cholestasis in Primary Sclerosing Cholangitis: Results of a Phase II Dose Finding Study.
In: Journal of Hepatology, Bd. 64:
S208-S209
Diese Liste wurde am
Sat Nov 23 23:04:11 2024 CET
erstellt.